Results 81 to 90 of about 8,307 (217)

Adverse reactions of biological therapies in patients with psoriasis [PDF]

open access: yes, 2017
Psoriasis is a chronic, immune-mediated disorder characterized by well demarcated, erythematous plaques covered by thick, silvery-white scales, most often located on the knees, elbows, sacral area and scalp.
Georgescu, Simona R.   +5 more
core   +4 more sources

The Chronic Face of a Reversible Syndrome: Persistent Neurogenic Symptoms in Posterior Reversible Encephalopathy Syndrome

open access: yesClinical Neuroimaging, Volume 3, Issue 1, 2026.
ABSTRACT Background Posterior reversible encephalopathy syndrome (PRES) is a well‐described neuro‐clinical syndrome characterized by acute‐onset symptoms, seizures, headache, visual disturbances, encephalopathy, and distinctive neuroimaging findings of vasogenic edema, typically in parieto‐occipital regions.
Ampuriire Nyakubaho   +3 more
wiley   +1 more source

Progressive Multifocal Leukoencephalopathy Diagnosed by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid in an HIV Patient

open access: yesFrontiers in Neurology, 2019
Metagenomic next-generation sequencing (mNGS) is a novel approach to identify pathogens undetected by conventional methods. Herein, we report a case in which mNGS was used to identify JC virus from the cerebrospinal fluid sample of an HIV positive ...
Huan Xia   +6 more
doaj   +1 more source

Review on the role of the human Polyomavirus JC in the development of tumors [PDF]

open access: yes, 2017
Almost one fifth of human cancers worldwide are associated with infectious agents, either bacteria or viruses, and this makes the possible association between infections and tumors a relevant research issue.
Manola Comar   +2 more
core   +1 more source

Stewardship of Molecular Diagnostics in Transplant Viral Infections

open access: yesTransplant Infectious Disease, Volume 28, Issue 1, January/February 2026.
ABSTRACT The transplant environment requires special considerations when testing for viral infections as immunosuppression results in atypical infection profiles. Microbes otherwise considered commensals or causing mild disease can lead to severe infections in transplant environments. Therefore, guidelines tend to recommend broader microbial testing in
Scott Sugden   +3 more
wiley   +1 more source

Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data

open access: yesBMC Neurology, 2019
Background Progressive multifocal leukoencephalopathy (PML) is a rare complication of patients treated with fingolimod. Case presentation Routine MRI eventually led to diagnosis of asymptomatic early PML that remained stable after discontinuation of ...
Tim Sinnecker   +13 more
doaj   +1 more source

Manufacturing and clinical applications of non‐CAR‐T immune effector cells

open access: yes
Transfusion, EarlyView.
Thane Kubik   +2 more
wiley   +1 more source

Refractory Status Epilepticus and Therapeutic Uncertainties: a Comprehensive Review on Targeting Neuroinflammation and Rationale for Developing a Platform Trial

open access: yesAdvanced Science, Volume 12, Issue 47, December 18, 2025.
Refractory status epilepticus (RSE) is a life‐threatening neurological emergency with high rates of death and long‐term disability, but treatments for it are often based on limited evidence. RSE is now understood to involve neuroinflammation, which has led to the exploration of anti‐inflammatory and immunomodulatory agents like Tocilizumab. Traditional
Shanika Samarasekera   +12 more
wiley   +1 more source

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation. [PDF]

open access: yes, 2011
Despite its common use in nonmyeloablative preparative regimens, the pharmacokinetics of fludarabine are poorly characterized in hematopoietic cell transplantation (HCT) recipients and exposure-response relationships remain undefined.
Brunstein, CG   +9 more
core   +1 more source

Successful Treatment of Facial Pseudolymphoma With Intravenous Rituximab: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Intravenous rituximab demonstrated significant efficacy in treating a case of refractory cutaneous pseudolymphoma that failed multiple conventional therapies, including corticosteroids, hydroxychloroquine, methotrexate, and biologics. The patient, a 42‐year‐old man, initially developed erythematous, nodular lesions on the face following dental
Elham Behrangi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy